GO:0070524 11-beta-hydroxysteroid dehydrogenase (NADP+) activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070524 defines the NADP+-dependent interconversion of an 11-beta-hydroxysteroid and an 11-oxosteroid, a reaction that controls local glucocorticoid availability.
• The reaction consumes NADP+ and produces NADPH and H+, linking steroid metabolism directly to cellular redox balance.
• Enzyme activity has been measured in placenta, adrenal gland, fetal and adult ovine tissues, toad bladder, and porcine placenta, showing broad but tissue-specific expression.
• Placental 11-beta-hydroxysteroid dehydrogenase activity differs between normotensive and pre-eclamptic pregnancies, implicating the enzyme in pregnancy-related pathology.
• Adrenal enzyme activity changes in response to stress, suggesting a role in the neuroendocrine stress axis.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal testing of this activity in disease and development.
Description
GO:0070524, 11-beta-hydroxysteroid dehydrogenase (NADP+) activity, is a molecular function that catalyzes the reversible conversion of an 11-beta-hydroxysteroid to an 11-oxosteroid using NADP+ as the electron acceptor, yielding NADPH and H+. This activity is central to prereceptor steroid metabolism because it determines the local concentration of active glucocorticoids such as cortisol and corticosterone, thereby modulating access to corticosteroid receptors. The enzyme has been studied across species and tissues, including porcine placenta, ovine adrenal and fetal tissues, human placenta, and toad bladder, where its activity influences ion transport and stress responses. Researchers value GO:0070524 because it connects redox biology, endocrine signaling, and tissue-specific steroid action in a single catalytic step. Understanding its regulation and genetic control is essential for dissecting pregnancy complications, adrenal physiology, and stress-related disorders.
11-beta-hydroxysteroid dehydrogenase (NADP+) activity At A Glance
| GO ID | GO:0070524 |
|---|---|
| GO term | 11-beta-hydroxysteroid dehydrogenase (NADP+) activity |
| Ontology | molecular_function |
| Synonym | beta-hydroxysteroid dehydrogenase; corticosteroid 11-beta-dehydrogenase activity |
| Major function | Catalyzes the NADP+-dependent interconversion of 11-beta-hydroxysteroids and 11-oxosteroids |
| Reaction direction | Reversible; NADP+ is reduced to NADPH with release of H+ |
| Tissue examples | Placenta, adrenal gland, fetal and adult ovine tissues, toad bladder |
| Physiological context | Controls local glucocorticoid availability and redox balance |
What Is GO:0070524?
In plain terms, GO:0070524 describes an enzyme activity that swaps a hydroxyl group and a hydrogen on a steroid at carbon 11, using NADP+ as the cofactor. The official definition states: Catalysis of the reaction: an 11-beta-hydroxysteroid + NADP+ = an 11-oxosteroid + NADPH + H+. This activity is synonymous with beta-hydroxysteroid dehydrogenase and corticosteroid 11-beta-dehydrogenase activity, and it is classified under the molecular_function aspect of the Gene Ontology.
Why Is 11-beta-hydroxysteroid dehydrogenase (NADP+) activity Important in Cell Biology?
GO:0070524 is important because it sits at the intersection of steroid hormone action and cellular redox metabolism. By converting 11-beta-hydroxysteroids to 11-oxosteroids and vice versa, the enzyme sets the local concentration of active glucocorticoids that can engage corticosteroid receptors. This prereceptor control influences placental function, adrenal responses to stress, and electrolyte transport in epithelia such as toad bladder. Because activity has been detected in diverse tissues and species, from porcine placenta to ovine fetal tissues, it is a broadly relevant target for endocrine, developmental, and reproductive research.
• Regulates local glucocorticoid availability, affecting corticosteroid receptor activation.
• Links steroid metabolism to NADP+/NADPH redox balance.
• Shows altered activity in pre-eclamptic versus normotensive pregnancies.
• Responds to stress in adrenal tissue, implicating it in neuroendocrine regulation.
• Expressed in fetal and adult ovine tissues, suggesting developmental roles.
• Detected in human placenta throughout pregnancy.
• Modulates ion transport in toad bladder, a model epithelium.
• Provides a mechanistic entry point for studying pregnancy complications.
• Enables comparative endocrinology across mammalian species.
• Supports CRISPR-based causal testing of steroid-metabolizing genes.
Molecular Mechanism of 11-beta-hydroxysteroid dehydrogenase (NADP+) activity
Substrate recognition and binding
In simple terms: The enzyme grabs a steroid molecule and holds it in place.
The activity acts on 11-beta-hydroxysteroids, positioning the steroid so that the carbon 11 position is accessible for catalysis. Tissue-specific assays in placenta and adrenal preparations show that substrate availability and local steroid concentrations influence measured activity.
NADP+ cofactor usage
In simple terms: NADP+ acts as the helper that accepts electrons during the reaction.
The reaction specifically uses NADP+ as the electron acceptor, producing NADPH and H+. This distinguishes GO:0070524 from NAD+-dependent dehydrogenase activities and ties the reaction to cellular redox pools.
Catalytic interconversion
In simple terms: The enzyme swaps a chemical group on the steroid, changing it from one form to another.
Catalysis converts an 11-beta-hydroxysteroid to an 11-oxosteroid, and the reaction is reversible under appropriate conditions. Activity measurements in porcine placenta and ovine tissues demonstrate that the direction and rate depend on substrate and cofactor availability.
Tissue-specific regulation of activity
In simple terms: Different tissues tune how much of this enzyme activity they show.
Enzyme activity varies across placenta, adrenal gland, fetal and adult ovine tissues, and toad bladder, indicating tissue-specific control. Adrenal activity changes in response to stress, and placental activity differs in pre-eclamptic pregnancies, showing physiological regulation.
Key Genes Involved in GO:0070524 11-beta-hydroxysteroid dehydrogenase (NADP+) activity
The genes and proteins below are directly linked to 11-beta-hydroxysteroid dehydrogenase (NADP+) activity in the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HSD11B1 | Encodes an 11-beta-hydroxysteroid dehydrogenase that interconverts active and inactive glucocorticoids | Target for studying glucocorticoid availability and stress responses |
| HSD11B2 | Encodes an 11-beta-hydroxysteroid dehydrogenase with NADP+-dependent activity | Studied in placenta and pregnancy complications |
| NR3C1 | Glucocorticoid receptor whose activation depends on local steroid availability | Downstream readout of enzyme activity |
| NR3C2 | Mineralocorticoid receptor influenced by 11-beta-hydroxysteroid dehydrogenase activity | Studied in epithelial ion transport |
| Placental 11-beta-HSD (porcine) | Measured enzyme activity in porcine placenta | Comparative reproductive endocrinology |
| Adrenal 11-beta-HSD | Adrenal enzyme activity responsive to stress | Neuroendocrine stress research |
| Ovine 11-beta-HSD | Characterized from gene to function in sheep | Developmental and fetal tissue studies |
| Human placental 11-beta-HSD | Activity measured during pregnancy | Pregnancy physiology and pathology |
| Toad bladder 11-beta-HSD | Modulates ion transport in epithelium | Comparative transport physiology |
| Fetal ovine 11-beta-HSD | Activity in fetal tissues | Developmental endocrinology |
| Adult ovine 11-beta-HSD | Activity in adult tissues | Tissue-specific regulation studies |
| Corticosteroid 11-beta-dehydrogenase | Synonym for the enzyme activity | Literature search and annotation |
| 11-dehydrocorticosterone target | Substrate/product in toad bladder studies | Epithelial transport assays |
| NADP+ cofactor pool | Provides oxidizing equivalents for the reaction | Redox biology research |
| NADPH product pool | Generated by the reaction | Cellular redox and biosynthesis studies |
| Pre-eclampsia-associated placental activity | Altered in pre-eclamptic pregnancies | Disease modeling |
| Normotensive pregnancy placental activity | Reference activity in normal pregnancy | Comparative studies |
| Stress-responsive adrenal activity | Changes with stress | Stress axis research |
How Is 11-beta-hydroxysteroid dehydrogenase (NADP+) activity Regulated?
Regulation of 11-beta-hydroxysteroid dehydrogenase (NADP+) activity is tissue-specific and physiological. Adrenal enzyme activity changes in response to stress, indicating neuroendocrine control. Placental activity differs between normotensive and pre-eclamptic pregnancies, suggesting regulation by pregnancy-related factors. Activity in toad bladder is influenced by 11-dehydrocorticosterone, showing substrate-level modulation. Developmental stage also matters, as fetal and adult ovine tissues display distinct activity profiles.
11-beta-hydroxysteroid dehydrogenase (NADP+) activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HSD11B2 | Pre-eclampsia and placental dysfunction | Placental trophoblast knockout or overexpression |
| HSD11B1 | Stress-related adrenal dysfunction | Adrenal cell point-mutation models |
| NR3C2 | Epithelial ion transport disorders | Toad bladder or mammalian epithelial knock-in |
| NR3C1 | Glucocorticoid signaling disorders | Reporter knock-in for receptor activation |
| Ovine 11-beta-HSD | Developmental endocrine biology | Fetal tissue knockout or overexpression |
Pre-eclampsia and pregnancy complications
Placental 11-beta-hydroxysteroid dehydrogenase activity has been compared between normotensive and pre-eclamptic pregnancies, revealing differences that may contribute to disease pathophysiology. Human placental activity during pregnancy has also been characterized, providing a baseline for interpreting pathological changes.
Stress-related adrenal dysfunction
Adrenal 11-beta-hydroxysteroid dehydrogenase activity responds to stress, linking the enzyme to neuroendocrine regulation and potentially to stress-related disorders. Adrenal enzyme characterization further supports its role in glucocorticoid metabolism.
Epithelial ion transport disorders
In toad bladder, 11-beta-hydroxysteroid dehydrogenase activity and 11-dehydrocorticosterone effects on ion transport demonstrate a role in epithelial physiology that may inform understanding of mineralocorticoid-sensitive transport.
From 11-beta-hydroxysteroid dehydrogenase (NADP+) activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of enzyme activity alter glucocorticoid target genes? | CRISPR knockout in placental or adrenal cells |
| Does a specific residue control NADP+ preference? | Point mutation at the cofactor-binding site |
| Can a tagged enzyme be tracked in live cells? | Knock-in of a fluorescent or epitope tag |
| Does overexpression change local steroid ratios? | Overexpression in epithelial or placental cells |
| Which tissues depend on this activity during development? | Tissue-specific knockout in ovine or murine models |
| How does stress alter enzyme activity? | Adrenal explant or in vivo stress model |
How to Study the 11-beta-hydroxysteroid dehydrogenase (NADP+) activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| NADP+ reduction assay | Enzyme activity via NADPH production | Tissue homogenate screening |
| Radiolabeled steroid conversion | Substrate-to-product conversion | Placental and adrenal activity |
| Mass spectrometry | Steroid substrate and product levels | Pregnancy and adrenal studies |
| RNA-seq | Expression of enzyme-encoding genes | Tissue comparison |
| Immunoblotting | Protein abundance | Expression validation |
| Ion transport assay | Epithelial transport response | Toad bladder physiology |
| Stress challenge model | Adrenal activity change | Neuroendocrine research |
| Comparative tissue panel | Activity across tissues | Developmental endocrinology |
Enzyme activity assays
Radiometric or spectrophotometric assays measuring conversion of 11-beta-hydroxysteroids to 11-oxosteroids with NADP+ are the direct way to quantify GO:0070524 activity in tissue homogenates or cell lysates.
Steroid profiling by mass spectrometry
Mass spectrometry can quantify substrate and product steroids, providing a readout of enzyme activity in biological samples such as placenta or adrenal tissue.
Transcript and protein analysis
RNA-seq and immunodetection can measure expression of genes encoding the enzyme, complementing activity measurements to distinguish expression from catalytic regulation.
Tissue-specific comparative studies
Comparing activity across fetal and adult tissues, or across species such as pig, sheep, and human, reveals developmental and species-specific patterns.
How CRISPR Can Be Used to Study GO:0070524 11-beta-hydroxysteroid dehydrogenase (NADP+) activity
Knockout
CRISPR knockout of genes encoding 11-beta-hydroxysteroid dehydrogenase can eliminate enzyme activity, allowing researchers to test whether observed steroid ratios and downstream receptor activation depend on this function.
Point Mutation
Point mutations can be introduced at predicted cofactor-binding or catalytic residues to dissect NADP+ preference and catalytic efficiency without deleting the entire protein.
Knock-in
Knock-in of epitope or fluorescent tags enables tracking of enzyme localization and abundance in tissues such as placenta or adrenal gland.
Overexpression
Overexpression models increase enzyme levels to test whether elevated activity alters local glucocorticoid availability and epithelial transport.
How EDITGENE Supports 11-beta-hydroxysteroid dehydrogenase (NADP+) activity Research
Researchers studying 11-beta-hydroxysteroid dehydrogenase (NADP+) activity-related genes often need to determine whether a candidate gene is causally involved in steroid metabolism, stress responses, or pregnancy complications. EDITGENE provides CRISPR-based cell models and screening services to move from correlation to causation.
Contact EDITGENE today to design your custom CRISPR model for 11-beta-hydroxysteroid dehydrogenase (NADP+) activity research.
Frequently Asked Questions About 11-beta-hydroxysteroid dehydrogenase (NADP+) activity
What is GO:0070524?
GO:0070524 is the Gene Ontology molecular function term for 11-beta-hydroxysteroid dehydrogenase (NADP+) activity, which catalyzes the reaction: an 11-beta-hydroxysteroid + NADP+ = an 11-oxosteroid + NADPH + H+.
What does 11-beta-hydroxysteroid dehydrogenase (NADP+) activity do?
It interconverts 11-beta-hydroxysteroids and 11-oxosteroids using NADP+ as a cofactor, thereby controlling local glucocorticoid availability and redox balance.
What genes are involved in 11-beta-hydroxysteroid dehydrogenase (NADP+) activity?
Genes encoding 11-beta-hydroxysteroid dehydrogenase enzymes, such as HSD11B1 and HSD11B2, are directly involved, with downstream effects on glucocorticoid and mineralocorticoid receptors.
Which tissues show this enzyme activity?
Activity has been measured in placenta, adrenal gland, fetal and adult ovine tissues, and toad bladder, among others.
How is 11-beta-hydroxysteroid dehydrogenase activity measured?
Common methods include NADP+ reduction assays, radiolabeled steroid conversion, and mass spectrometry of substrate and product steroids.
Is 11-beta-hydroxysteroid dehydrogenase activity linked to pre-eclampsia?
Yes, placental activity differs between normotensive and pre-eclamptic pregnancies, suggesting a role in disease.
Does stress affect this enzyme activity?
Adrenal 11-beta-hydroxysteroid dehydrogenase activity changes in response to stress, indicating neuroendocrine regulation.
What is the difference between NADP+ and NAD+ dependent activity?
GO:0070524 specifically uses NADP+ as the electron acceptor, producing NADPH and H+, which distinguishes it from NAD+-dependent dehydrogenases.
Can CRISPR be used to study this activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can test causal roles of the enzyme in steroid metabolism and disease.
Why is this GO term important for drug discovery?
Because the enzyme controls local glucocorticoid levels, modulating it could influence pregnancy complications, stress responses, and epithelial transport.
Conclusion
GO:0070524, 11-beta-hydroxysteroid dehydrogenase (NADP+) activity, is a well-defined molecular function that links steroid metabolism to redox biology and local glucocorticoid action. Its activity has been documented across placenta, adrenal gland, fetal and adult tissues, and epithelial models, with physiological changes in pregnancy and stress. CRISPR-based models offer a direct route to test causality and to explore therapeutic hypotheses in endocrine and reproductive disease.
References
- 1. Klemcke HG et al.. 1996. Porcine placental 11 beta-hydroxysteroid dehydrogenase activity.. Biol Reprod 55(1):217-23 PMID: 8793078
- 2. Shimojo M et al.. 1996. Adrenal 11 beta-hydroxysteroid dehydrogenase.. Endocr Res 22(4):771-80 PMID: 8969940
- 3. Yang K. 1995. Ovine 11 beta-hydroxysteroid dehydrogenase: from gene to function.. Endocr Res 21(1-2):367-77 PMID: 7588400
- 4. McCalla CO et al.. 1998. Placental 11 beta-hydroxysteroid dehydrogenase activity in normotensive and pre-eclamptic pregnancies.. Steroids 63(10):511-5 PMID: 9800281
- 5. Zallocchi M et al.. 2004. Adrenal 11-beta hydroxysteroid dehydrogenase activity in response to stress.. Can J Physiol Pharmacol 82(6):422-5 PMID: 15381967
- 6. Blasco MJ et al.. 1986. 11 beta-Hydroxysteroid dehydrogenase activity of the human placenta during pregnancy.. Horm Metab Res 18(9):638-41 PMID: 3465674
- 7. Brem AS et al.. 1993. Activity of 11 beta-hydroxysteroid dehydrogenase in toad bladder: effects of 11-dehydrocorticosterone.. Am J Physiol 264(5 Pt 2):F854-8 PMID: 8498539
- 8. Kim EK et al.. 1995. Characterization of 11 beta-hydroxysteroid dehydrogenase activity in fetal and adult ovine tissues.. Reprod Fertil Dev 7(3):377-83 PMID: 8606946
